⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11292475 | 0.83 | — | — | |
| SCHEMBL27605329 | 0.76 | — | — | |
| SCHEMBL4076012 | 0.74 | — | — | |
| SCHEMBL4098039 | 0.74 | LMNA (0.42) | — | |
| SCHEMBL27869627 | 0.72 | LMNA (0.46) | — | |
| SCHEMBL10528718 | 0.72 | LMNA (0.46) | — | |
| SCHEMBL11376263 | 0.70 | — | — | |
| SCHEMBL10341250 | 0.70 | — | — | |
| SCHEMBL10906254 | 0.70 | HTR2A (0.38) | — | |
| SCHEMBL5634731 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170128453-A1 | NOVEL USES | INTRA-CELLULAR THERAPIES, INC. (US) | 2017-05-11 | — | — | US | claimed |
| US-20160038494-A1 | NOVEL COMBINATION | INTRA-CELLULAR THERAPIES, INC. | 2016-02-11 | — | — | US | claimed |
| EP-2968338-A2 | NOVEL USES | Intra-Cellular Therapies, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| EP-2956141-A1 | NOVEL USES | Intra-Cellular Therapies, Inc. (US) | 2015-12-23 | — | — | EP | claimed |
| US-20150353556-A1 | ORGANIC COMPOUNDS | LI PENG (US) | 2015-12-10 | — | — | US | claimed |
| US-20140315868-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2014-10-23 | — | — | US | claimed |
| WO-2014145617-A2 | NOVEL USES | INTRA-CELLULAR THERAPIES, INC. (US) | 2014-09-18 | — | — | WO | claimed |
| WO-2014127331-A1 | NOVEL USES | INTRA-CELLULAR THERAPIES, INC. (US) | 2014-08-21 | — | — | WO | claimed |
| US-20120136013-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES. INC. | 2012-05-31 | — | — | US | claimed |
| US-20120094966-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. | 2012-04-19 | — | — | US | claimed |
| US-20110281832-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. | 2011-11-17 | — | — | US | claimed |
| EP-2367428-A1 | ORGANIC COMPOUNDS | Intra-Cellular Therapies, Inc. (US) | 2011-09-28 | — | — | EP | claimed |
| EP-2367430-A1 | ORGANIC COMPOUNDS | Intra-Cellular Therapies, Inc. (US) | 2011-09-28 | — | — | EP | claimed |
| EP-2367431-A1 | ORGANIC COMPOUNDS | Intra-Cellular Therapies, Inc. (US) | 2011-09-28 | — | — | EP | claimed |
| WO-2010065147-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2010-06-10 | — | — | WO | claimed |
| WO-2010065153-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2010-06-10 | — | — | WO | claimed |
| WO-2010065152-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2010-06-10 | — | — | WO | claimed |
| US-20210213018-A1 | NOVEL USES | INTRA-CELLULAR THERAPIES, INC. (US) | 2021-07-15 | — | — | US | disclosed |
| WO-2010065147-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2010-06-10 | — | — | WO | disclosed |
| WO-2010065153-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2010-06-10 | — | — | WO | disclosed |